FRDD

Forensically-Relevant Drug Database

NPS Discover

Description

Preferred Drug Name

Spirochlorphine

Brief Description

Spirochlorphine (R-6890) is a novel synthetic opioid characterized as an “orphine” analogue with a spiropiperidine group. It bears structural similarity to other benzimidazolones (e.g., brorphine, chlorphine, N-propionitrile chlorphine). Spirochlorphine was first researched in the 1970s as a narcotic analgesic and has since been reported in drug materials in North America and Europe.1,2 Spirochlorphine was first identified by our laboratory in May 2025 and later confirmed after acquiring standard reference material.

Structure


Nomenclature

Formal Name (IUPAC)

8-[1-(4-chlorophenyl)ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one

Synonyms

R-6890

Identifiers

CAS Numbers

3222-88-6

Chemistry

Chemical Formula

C21H24ClN3O

Molecular Mass

369.90

Molecular Ion

369

Exact Mass

370.1681

SMILES

O=C1C(CCN2C(C(C=C3)=CC=C3Cl)C)(CC2)N(C4=CC=CC=C4)CN1

InChI String

InChI=1S/C21H24ClN3O/c1-16(17-7-9-18(22)10-8-17)24-13-11-21(12-14-24)20(26)23-15-25(21)19-5-3-2-4-6-19/h2-10,16H,11-15H2,1H3,(H,23,26)

InChI Key

KFEYPBZJPJJRFX-UHFFFAOYSA-N

GCMS Analytics

Lab

CFSRE (Willow Grove, PA)

Comments

Sample Preparation:

Drug Materials: Dilution in methanol or acid / base extraction

Drug Standards: Dilution in methanol

Instrument:Agilent 5975 Series GC/MSD System
Column:Agilent J&W DB-1 (12 m x 200 µm x 0.33 µm)
Carrier Gas:Helium (Flow: 1.46 mL/min)
Temperatures:

Injection Port: 265 °C

Transfer Line: 300 °C

MS Source: 230 °C

MS Quad: 150 °C

Oven Program: 50 °C for 0 min, 30 °C/min to 340 °C for 2.3 min

Injection Parameters:Injection Type: Splitless, Injection Volume: 1 µL
MS Parameters:Mass Scan Range: 40-550 m/z

 

Images

Fragments

175
139
230
56
103

HRMS Analytics

Lab

CFSRE (Willow Grove, PA)

Comments

Sample Preparation:

Toxicology Samples: Liquid-liquid extraction

Drug Materials: Dilution of sample in mobile phase

Instrument:

Sciex TripleTOF® 5600+, Shimadzu Nexera XR UHPLC

Sciex X500R, Sciex ExionLC

Column:Phenomenex® Kinetex C18 (50 mm x 3.0 mm, 2.6 µm)
Mobile Phase:

A: Ammonium formate (10 mM, pH 3.0)

B: Methanol/acetonitrile (50:50)

Flow rate: 0.4 mL/min

Gradient:Initial: 95A:5B; 5A:95B over 13 min; 95A:5B at 15.5 min
Temperatures:

Autosampler: 15 °C

Column Oven: 30 °C

Source Heater: 600 °C

Injection Parameters:Injection Volume: 10 µL
QTOF Parameters:

TOF MS Scan Range: 100-510 Da

Precursor Isolation: SWATH® acquisition (27 windows)

Fragmentation: Collison Energy Spread (35±15 eV)

MS/MS Scan Range: 50-510 Da

 

Images

Fragments

139.0306
370.1658
232.1436
127.0863
103.0542

Drug Origins and Uses

Drug Origins and Uses

Illicit, Synthetic

Biological Effects

Biological Effects

Sedative/Hypnotic

Target Receptor or Neurotransmitter

Target Receptor or Neurotransmitter

MOR

Pharmacodynamics

Pharmacodynamics

Agonist

Drug Control

US Controlled Substance Schedule

Not Controlled


Pharmacology Literature

Source

European Journal of Pharmacology

Title

Receptor affinity and pharmacological potency of a series of narcotic analgesic, anti-diarrheal and neuroleptic drugs

Reference Link


Published January 27, 2026